Induction of tumor necrosis factor-α as a cause of bleomycin-related toxicity

被引:0
|
作者
Sleijfer, S
Vujaskovic, Z
Limburg, PC
Koops, HS
Mulder, NH
机构
[1] Univ Groningen Hosp, Dept Med Oncol, NL-9700 RB Groningen, Netherlands
[2] Univ Groningen Hosp, Dept Radiotherapy, Groningen, Netherlands
[3] Univ Groningen Hosp, Dept Rheumatol, Groningen, Netherlands
[4] Univ Groningen Hosp, Dept Surg Oncol, Groningen, Netherlands
关键词
bleomycin; toxicity; germ cell tumor; tumor necrosis factor-alpha; interleukin-1; beta; transforming growth factor-beta;
D O I
10.1002/(SICI)1097-0142(19980301)82:5<970::AID-CNCR24>3.0.CO;2-X
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND, The application of bleomycin is characterized by acute side effects, such as fever, chills, and sometimes hypotension and tachypnea. Furthermore, bleomycin is known to induce pneumonitis. There are several indications that the induction of cytokines by bleomycin is involved in the development of these side effects. METHODS, In this study, the authors determined the plasma levels of tumor necrosis factor-alpha (TNF-alpha), interleukin-1 beta (IL-1 beta), and transforming growth factor-beta (TGF-beta) before and after bleomycin infusion in 14 patients treated for disseminated nonseminomatous germ cell tumor. RESULTS, Compared with the pretreatment value, TNF-alpha was significantly increased 3, 4.5, and 24 hours after bleomycin infusion. For IL-1 beta and TGF-beta, no significant alterations were observed within 24 hours after administration of bleomycin. CONCLUSIONS. The increase in TNF-alpha after administration of bleomycin suggests a role for this cytokine in the development of the acute side effects and probably also in the occurrence of bleomycin-induced pulmonary toxicity. The involvement of IL-1 beta and TGF-beta deserve further study. (C) 1998 American Cancer Society.
引用
收藏
页码:970 / 974
页数:5
相关论文
共 50 条
  • [31] In vivo and in vitro evidence for the involvement of tumor necrosis factor-α in the induction of leptin by lipopolysaccharide
    Finck, BN
    Kelley, KW
    Dantzer, R
    Johnson, RW
    ENDOCRINOLOGY, 1998, 139 (05) : 2278 - 2283
  • [32] Osmotic response element is required for the induction of aldose reductase by tumor necrosis factor-α
    Iwata, T
    Sato, S
    Jimenez, J
    McGowan, M
    Moroni, M
    Dey, A
    Ibaraki, N
    Reddy, VN
    Carper, D
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (12) : 7993 - 8001
  • [33] Role of tumor necrosis factor-α in stroke
    Cechetto, DF
    STROKE, 2001, 32 (08) : 1757 - 1758
  • [34] Tumor necrosis factor-α in parapneumonic effusion
    Porcel, JA
    Vives, M
    Esquerda, A
    CHEST, 2005, 127 (05) : 1868 - 1869
  • [35] Tumor necrosis factor-α converting enzyme
    Black, RA
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2002, 34 (01): : 1 - 5
  • [36] Tumor necrosis factor-α and neuronal development
    Bessis, A
    Bernard, D
    Triller, A
    NEUROSCIENTIST, 2005, 11 (04): : 277 - 281
  • [37] Tumor necrosis factor-α and autonomic dysfunction
    不详
    NEUROSCIENTIST, 2007, 13 (03): : 195 - 195
  • [38] Tumor necrosis factor-α antagonists and neuropathy
    Stuebgen, Joerg-Patrick
    MUSCLE & NERVE, 2008, 37 (03) : 281 - 292
  • [39] Induction of T-kininogen and tumor necrosis factor-α by macrophage migration inhibitory factor in vivo
    Nishihira, J
    Mizue, Y
    Sakamoto, W
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1999, 25 (06): : 557 - 562
  • [40] Regulation of tumor necrosis factor-α and tumor necrosis factor converting enzyme in human osteoarthritis
    Amin, AR
    OSTEOARTHRITIS AND CARTILAGE, 1999, 7 (04) : 392 - 394